A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2014

Conditions
Ocular HypertensionOpen Angle-glaucoma
Interventions
DRUG

ONO-9054

DRUG

Latanoprost

Trial Locations (12)

10029

New York Clinical Site, New York

16066

Cranberry Township Clinical Site, Cranberry Township

19104

Philadelphia Clinical Site, Philadelphia

27262

High Point Clinical Site, High Point

30076

Roswell Clinical Site, Roswell

30260

Morrow Clinical Site, Morrow

78731

Austin Clinical Site, Austin

90048

Los Angeles Clinical Site, Los Angeles

91105

Pasadena Clinical Site, Pasadena

91345

Mission Hills Clinical Site, Mission Hills

92663

Newport Beach Clinical Site, Newport Beach

94954

Petaluma Clinical Site, Petaluma

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY